Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20200413047059N1Phase 2Completed
Phase 2, randomised trial of chlorhexidine in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Incidence of ventilator-associated pneumonia. Started Jul 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20200413047059N1.